Roots Analysis
SEPTEMBER 4, 2024
Roots Analysis has conducted an exhaustive study on In Vitro Diagnostics Market featuring the current market landscape and future opportunity for the companies engaged in offering in vitro diagnostic solutions, over a span of 11 years. The figure pasted below shows a summarized representation of SWOT points affiliated with IVD Market.
XTalks
APRIL 13, 2021
New data from the Plant Based Foods Association (PBFA) and The Good Food Institute (GFI) shows that the retail sales of plant-based foods in the US grew by 27 percent in 2020, bringing its total market value to $7 billion. of the $7 billion market. Plant-Based Milk Sales. Plant-Based Meat Sales. billion in sales in 2020.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
AUGUST 20, 2020
It has since expanded nationwide, threatening an important market for many Big Pharma players. . At the time, Wolfe Research analyst Tim Anderson wondered whether the decline was the “canary in the coalmine” for the rest of the industry, which has been relying on the lucrative China market for revenue growth.
Roots Analysis
AUGUST 15, 2024
This article explores the role of molecular diagnostics in early cancer detection, highlighting the benefits and future prospects in the oncology molecular diagnostics market. A growing sub-segment of the overall market is oncology molecular diagnostics market, which is helping fill the unmet need for early diagnosis.
Pharmaceutical Technology
JANUARY 27, 2023
Jakub Hlávka, PhD, the executive director of the Healthcare Markets Initiative and Fellow at the University of Southern California Schaeffer Center, suggests the strategy behind this new warranty program could “minimise the [financial and clinical] risk for the provider and for the patient”.
Roots Analysis
FEBRUARY 23, 2024
With the rising demand for antibody therapeutics in the recent past, the domain of antibody discovery has seen a significant market growth towards outsourcing. Companies are now turning to contract research organizations to help accelerate their workflow. To date, he has contributed to over seven full length market research projects.
The Pharma Data
DECEMBER 31, 2020
Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. a publicly-listed company investing in blockchain technology solutions for capital markets and other sectors that can benefit from tokenization. He is currently the CEO of BlockchainK2 Corp.,
Expert insights. Personalized for you.
40 
Let's personalize your content